| Literature DB >> 17659209 |
A L Casey1, P A Lambert, T S J Elliott.
Abstract
Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to beta-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci.Entities:
Mesh:
Year: 2007 PMID: 17659209 DOI: 10.1016/S0924-8579(07)72175-1
Source DB: PubMed Journal: Int J Antimicrob Agents ISSN: 0924-8579 Impact factor: 5.283